Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Diseases of the Colon and Rectum|February 5, 2005
Urgent subtotal colectomy for severe inflammatory bowel diseaseNeil H Hyman, Peter Cataldo, Turner OslerSurgical Endoscopy|August 19, 2009
The high yield of 1-year colonoscopy after resection: is it the handoff?Neil Hyman, Jesse Moore, Peter Cataldo, et al.American Journal of Surgery|September 11, 2007
Understanding variation in the management of rectal cancer: the potential of a surgeon-initiated databaseNeil Hyman, Christopher Healey, Turner Osler, et al.Journal of the American College of Surgeons|February 21, 2009
Anastomotic leaks after bowel resection: what does peer review teach us about the relationship to postoperative mortality?Neil H Hyman, Turner Osler, Peter Cataldo, et al.Annals of Surgery|August 26, 2011
Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancerJulio Garcia-Aguilar, Zhenbin Chen, David D Smith, et al.Annals of Surgical Oncology|July 15, 2011
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trialJulio Garcia-Aguilar, Qian Shi, Charles R Thomas, et al.International Journal of Radiation Oncology, Biology, Physics|May 26, 2024
Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and GuidelinesChristopher J Anker, Leila T Tchelebi, J Eva Selfridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA TrialFloris S Verheij, Dana M Omer, Hannah Williams, et al.Pageof 1